Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Avoiding Physician Liability for Off-Label Use of Drugs and Devices
Plaintiffs' attorneys continually seek new and novel ways to circumvent the defenses afforded to manufacturers of FDA-approved medical products, such as federal preemption and the learned intermediary doctrine. At the same time, “it is undisputed that the prescription of drugs [and devices] for unapproved uses is commonplace in modern medical practice and ubiquitous in certain specialties.” Washington Legal Foundation v. Henney, 202 F.3d 331, 333 (D.C. Cir. 2000) (internal citations omitted.) The increased level of enforcement activity by the United States Food and Drug Administration (FDA) has focused the attention of consumers and the plaintiffs' bar on the increased frequency with which physicians prescribe FDA-approved drugs and medical devices for unapproved uses. Plaintiffs' attorneys increasingly choose to name prescribing physicians in their products liability suits as co-defendants, pleading both medical malpractice and other associated tort claims against these physicians, and often premising such claims upon the decision to prescribe for a so-called “off-label” or unapproved use. Thus, the continuing expansion of off-label uses of drugs and devices has led to numerous potential legal minefields for the prescribing physicians.
Often, physicians do not realize that, to a lay person, the use of a drug or device for an indication that has not been approved by the FDA may sound as though the physicians are somehow “experimenting” on their patients with off-label uses. While “[a] physician is free to use a medical device for an off-label purpose if, in the physician's medical judgment, he or she believes that use of the device will benefit the patient,” it also stands to reason that “[b]ecause the off-label use ' is a matter of medical judgment, a physician may be subject to medical malpractice liability for the exercise of that judgment.” Alvarez v. Smith, 714 So.2d 652, 653 (Fla. App. Ct. 1998). It is important for prescribing and implanting physicians and their counsel to be aware of the murky and shifting arguments plaintiffs may make against decisions to prescribe off-label. This three-part article explores the potential theories of liability for off-label prescriptions that have been employed, with mixed success. It will also discuss strategies for physicians to use to protect their power to prescribe approved drugs and devices in an off-label manner, in their exclusive medical judgment, while protecting themselves from a threat of potential future litigation or liability.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
Major Differences In UK, U.S. Copyright Laws
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
Beach Boys Songs Written Decades Ago Triggered Current Quarrel With Lawyers
There's current litigation in the ongoing Beach Boys litigation saga. A lawsuit filed in 2019 against Nevada residents Mike Love and his wife Jacquelyne in the U.S. District Court for the District of Nevada that alleges inaccurate payment by the Loves under the retainer agreement and seeks $84.5 million in damages.
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Warehouse Liability: Know Before You Stow!
As consumers continue to shift purchasing and consumption habits in the aftermath of the pandemic, manufacturers are increasingly reliant on third-party logistics and warehousing to ensure their products timely reach the market.